{"slideshow_credits": null, "snippet": "Rising Chinese demand for drugs is a boon for foreign companies, but bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.", "abstract": "Rising Chinese demand for drugs is a boon for foreign companies, but selling pharmaceuticals and other health care products in China is increasingly fraught with peril; bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/07/17/business/global/for-drug-makers-china-becomes-a-perilous-market.html", "lead_paragraph": "Rising Chinese demand for drugs is a boon for foreign companies, but bribery allegations against GlaxoSmithKline underscore the risk of scrutiny from officials.", "headline": {"main": "For Global Drug Manufacturers, China Becomes a Perilous Market", "print_headline": "For Global Drug Manufacturers, China Becomes a Perilous Market"}, "_id": "51e575217e0d9c0839d3010c", "word_count": "1221", "multimedia": [{"height": 126, "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 322, "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-articleLarge.jpg", "legacy": {"xlarge": "images/2013/07/17/business/Drug-span/Drug-1374016413062-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "322"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/07/17/business/Drug-span/Drug-1374016413062-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-07-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "China", "name": "glocations", "is_major": "Y", "rank": "2"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "3"}], "blog": [], "subsection_name": "Global Business", "type_of_material": "News"}